Raju Prasad

Companies

• CRISPR TherapeuticsChief financial officer Mar 14, 2023 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• CRISPR Therapeutics CRSP14,815 shares²$739.4K at $49.91Aug 7, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 7, 2026Gift 750 shares of CRISPR Therapeutics²
• Mar 23, 2026Sold 3,708 shares at $46.78 of CRISPR Therapeutics³
• Mar 20, 2026Exercised options 6,250 shares of CRISPR Therapeutics³
• Mar 16, 2026Gift 750 shares of CRISPR Therapeutics⁴
• Mar 16, 2026Sold 4,021 shares at $48.26 of CRISPR Therapeutics⁴
• Mar 16, 2026Sold 5,848 shares at $48.26 of CRISPR Therapeutics⁴
• Mar 14, 2026Exercised options 6,875 shares of CRISPR Therapeutics⁴
• Mar 14, 2026Exercised options 10,000 shares of CRISPR Therapeutics⁴
• Jan 22, 2026Sold 34,972 shares at $60.19 of CRISPR Therapeutics⁵
• Jan 22, 2026Exercised options 34,972 shares at $45.15 of CRISPR Therapeutics⁵
• Jan 6, 2026Sold 5,763 shares at $60.21 of CRISPR Therapeutics⁶
• Jan 6, 2026Sold 5,004 shares at $60.00 of CRISPR Therapeutics⁶
• Jan 6, 2026Sold 18,933 shares at $60.18 of CRISPR Therapeutics⁶
• Jan 6, 2026Exercised options 6,339 shares at $44.31 of CRISPR Therapeutics⁶
• Jan 6, 2026Exercised options 23,361 shares at $45.15 of CRISPR Therapeutics⁶
• Dec 22, 2025Sold 1,000 shares at $56.89 of CRISPR Therapeutics⁷
• Dec 22, 2025Sold 5,472 shares at $56.33 of CRISPR Therapeutics⁷
• Dec 22, 2025Sold 3,528 shares at $55.10 of CRISPR Therapeutics⁷
• Mar 21, 2025Sold 2,197 shares at $41.23 of CRISPR Therapeutics⁸
• Mar 20, 2025Exercised options 6,250 shares of CRISPR Therapeutics⁸
• Mar 17, 2025Sold 3,762 shares at $41.80 of CRISPR Therapeutics⁹
• Mar 14, 2025Exercised options 10,000 shares of CRISPR Therapeutics⁹
• Mar 15, 2024Sold 3,524 shares at $72.69 of CRISPR Therapeutics¹⁰
• Mar 14, 2024Exercised options 10,000 shares of CRISPR Therapeutics¹⁰